BRIEF-Oncolytics Biotech Says Data Backs Pelareorep in KRAS‑Mutant mCRC

Reuters12-16 22:49

BRIEF-<a href="https://laohu8.com/S/ONCWF">Oncolytics Biotech</a> Says Data Backs Pelareorep in KRAS‑Mutant mCRC

Dec 16 (Reuters) - Oncolytics Biotech Inc ONCY.O:

ONCOLYTICS BIOTECH® ANNOUNCES PROMISING EFFICACY AND TRANSLATIONAL DATA SUPPORTING PELAREOREP IN KRAS-MUTANT METASTATIC COLORECTAL CANCER

Source text: ID:nBw50VDYNa

Further company coverage: ONCY.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2591938240?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-16 22:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2591938240","market":"fut","top_or_hot":-1,"title":"BRIEF-Oncolytics Biotech Says Data Backs Pelareorep in KRAS‑Mutant mCRC","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ONCWF\">Oncolytics Biotech</a> Says Data Backs Pelareorep in KRAS‑Mutant mCRC</title></head><body><p><span>Dec 16 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/ONCY\">Oncolytics Biotech Inc</a> <span>ONCY.O</span>:</p><ul><li><p>ONCOLYTICS BIOTECH® ANNOUNCES PROMISING EFFICACY AND TRANSLATIONAL DATA SUPPORTING PELAREOREP IN KRAS-MUTANT METASTATIC COLORECTAL CANCER</p></li></ul><p>Source text: <span>ID:nBw50VDYNa</span></p><p>Further company coverage: <span>ONCY.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Oncolytics Biotech Says Data Backs Pelareorep in KRAS‑Mutant mCRC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Oncolytics Biotech Says Data Backs Pelareorep in KRAS‑Mutant mCRC\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-16 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ONCWF\">Oncolytics Biotech</a> Says Data Backs Pelareorep in KRAS‑Mutant mCRC</title></head><body><p><span>Dec 16 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/ONCY\">Oncolytics Biotech Inc</a> <span>ONCY.O</span>:</p><ul><li><p>ONCOLYTICS BIOTECH® ANNOUNCES PROMISING EFFICACY AND TRANSLATIONAL DATA SUPPORTING PELAREOREP IN KRAS-MUTANT METASTATIC COLORECTAL CANCER</p></li></ul><p>Source text: <span>ID:nBw50VDYNa</span></p><p>Further company coverage: <span>ONCY.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ONCY","symbol_name":"Oncolytics Biotech Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA49DMGL:1","article_id":"2591938240","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2591938240","pubTimestamp":1765896541,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Oncolytics Biotech Says Data Backs Pelareorep in KRASMutant mCRCDec 16 (Reuters) - Oncolytics Biotech Inc ONCY.O:ONCOLYTICS BIOTECH ANNOUNCES PROMISING EFFICACY AND TRANSLATIONAL DATA SUPPORTING","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ONCY":"Oncolytics Biotech Inc","BK4139":"生物科技"},"translate_title":"简介-Oncolytics Biotech表示数据支持Pelareorep治疗KRAS突变型mCRC","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONCY":0.9},"content_text":"BRIEF-Oncolytics Biotech Says Data Backs Pelareorep in KRAS‑Mutant mCRCDec 16 (Reuters) - Oncolytics Biotech Inc ONCY.O:ONCOLYTICS BIOTECH® ANNOUNCES PROMISING EFFICACY AND TRANSLATIONAL DATA SUPPORTING PELAREOREP IN KRAS-MUTANT METASTATIC COLORECTAL CANCERSource text: ID:nBw50VDYNaFurther company coverage: ONCY.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2591938240","isCrawlerRequest":true}